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Abstract 
Background: Fatigue is a disabling, poorly understood symptom in children and adolescents 
with multiple sclerosis (caMS), for which effective treatments are lacking. In paediatric 
Chronic Fatigue Syndrome (CFS), effective psychological interventions have been developed 
based on psychosocial factors associated with fatigue. This study aimed to identify 
potentially modifiable factors of fatigue in caMS by comparing caMS, adolescents with CFS, 
healthy adolescents and their parents on measures of fatigue, psychosocial factors, and 
neurocognitive functioning. 
Methods: 175 participants including 30 caMS (15 fatigued, 15 non-fatigued), 30 adolescents 
with CFS, 30 healthy controls, and their parents were compared on measures of self- and 
parent-reported fatigue, adolescent and parent cognitive behavioural responses to symptoms, 
sleep, psychological difficulties, parental distress and objectively measured neurocognitive 
functioning. 
Results: Fatigue severity, functional impairment and cognitive behavioural responses to 
symptoms were equivalent in fatigued caMS and adolescents with CFS, and were 
significantly higher than in healthy controls and non-fatigued caMS. Neurocognitive 
functioning was impaired in both caMS groups, but was normal in adolescents with CFS and 
healthy controls. No between-group differences were identified in adolescent sleep behaviour 
or psychological difficulties. Parents of all illness groups had more unhelpful cognitions than 
parents of healthy controls. Psychological distress was elevated in parents of both fatigued 
groups. 
Conclusions: Fifty percent of caMS reported clinically significant fatigue. Similarities 
between adolescent and parent cognitive behavioural factors in fatigued caMS and 
adolescents with CFS suggest important potential targets for intervention. Both fatigued and 
non-fatigued caMS had cognitive difficulties, suggesting that fatigue may need targeted 
intervention. 
Keywords: Adolescence; Chronic Fatigue Syndrome; Fatigue; Multiple Sclerosis; Paediatric  
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Introduction 
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central 
nervous system, typically diagnosed in young adults (Murray, 2006). With a UK incidence 
rate of <1 in 100,000, paediatric MS is rare (Absoud et al., 2013). Children and adolescents 
with MS (caMS) experience similar physical symptoms to adults with MS, including sensory 
and motor impairments, visual disturbances and bladder and bowel dysfunction (Compston & 
Coles, 2008). For caMS, however, physical symptoms tend to be much less severe than in 
adults with MS.  Cognitive symptoms cause greater disturbance in caMS  as deficits in 
memory, language and attention and processing speed can have potentially long-term, serious 
consequences for school performance and academic attainment (Amato et al., 2010). Fatigue 
is also one of the most pervasive and disabling symptoms of MS (Giovannoni, 2006). In 
caMS, fatigue levels ranging from 9-76% have been reported in studies carried out across 
Europe and North America, with no clear reason for variability in reports. (Carroll, Chalder, 
Hemingway, Heyman, & Moss‐Morris, 2016b). 
Despite its impact, fatigue is a poorly understood symptom in paediatric MS, for which 
effective treatments are lacking. A recent systematic review of 12 studies that explored 
factors associated with fatigue in caMS indicated that fatigue is unrelated to clinical or 
demographic factors, but is associated with psychosocial factors including depressed mood, 
impaired school performance and lower quality of life. Some evidence also suggested that 
fatigued caMS may have impaired performance on some neurocognitive tasks (Carroll et al., 
2016b). This systematic review highlighted the paucity of psychosocial factors explored in 
the context of fatigue, with most studies focusing on associations between fatigue and 
depressed mood. Few studies have investigated other potentially modifiable psychosocial 
factors related to fatigue, such as cognitive and behavioural responses to symptoms e.g. 
catastrophising, symptom focusing and avoidance behaviour. Additionally, no previous 
studies have compared psychosocial factors or neurocognitive functioning between fatigued 
and non-fatigued caMS. 
To improve our understanding of fatigue in paediatric MS, it would be helpful to learn 
from other conditions where fatigue is better understood. However, despite a growing body 
of evidence that fatigue is one of the most universally experienced symptoms in paediatric 
long-term conditions, research on factors related to fatigue in this context is still relatively 
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sparse (Crichton, Knight, Oakley, Babl, & Anderson, 2015). Some exceptions to this are 
cancer, juvenile idiopathic arthritis, and Chronic Fatigue Syndrome (CFS) where a wider 
body of evidence has contributed to an improved understanding of fatigue. In cancer and 
rheumatoid arthritis, the aetiology of fatigue appears to be both treatment and disease related 
(Armbrust et al., 2016; Nunes et al., 2018) but in MS fatigue has not been linked to treatment.  
This paper therefore draws largely on the adult MS and adolescent Chronic Fatigue 
Syndrome (CFS) literature, where empirically based overlapping biopsychosocial cognitive-
behavioural models of fatigue have been developed. 
Adolescent Chronic Fatigue Syndrome (CFS), an illness characterised by persistent, 
disabling mental and physical fatigue (Lievesley, Rimes, & Chalder, 2014; Moss-Morris et 
al., 2012). These models posit that fatigue is triggered by biological factors, then perpetuated 
by the interaction between these factors and individuals’ cognitive, behavioural and 
emotional responses (van Kessel & Moss-Morris, 2006). Cognitive responses such as 
perceiving fatigue as an uncontrollable symptom, and behavioural responses such as 
excessive activity when symptoms abate and limited activity when they reappear, have been 
associated with increased fatigue. The reciprocal relationship between fatigue and emotional 
factors such as depressed mood and anxiety may also contribute to persistent fatigue (Jopson 
& Moss-Morris, 2003; Knoop, van Kessel, & Moss-Morris, 2012; Lievesley et al., 2014; 
Skerrett & Moss-Morris, 2006). It is worth noting that a recent meta-analysis showed that 
these perpetuating factors appear to be transdiagnostic in fatigue across a wide range of 
medical conditions (Menting et al., 2018).    
The family-focused cognitive behavioural model of adolescent CFS highlights the role 
of parental factors such as maternal distress and parents’ cognitive and behavioural responses 
to their child’s symptoms in perpetuating fatigue (Lievesley et al., 2014). Parents’ 
perceptions of their child’s vulnerability, parental overprotection and parental distress have 
also been associated with child adjustment, increased symptoms, and school absence across a 
range of conditions, yet these factors have seldom been explored in paediatric MS research 
(Lievesley et al., 2014; Palermo, Valrie, & Karlson, 2014; Spurrier et al., 2000). Some 
previous studies have assessed self- and parent-reports of children’s fatigue. Findings 
regarding concordance between self- and parent-reports have been mixed, demonstrating the 
need to collect multi-rater perspectives to get a clearer picture of children’s fatigue (Carroll et 
al., 2016b). 
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In adult MS and adolescent CFS, cognitive behavioural therapy (CBT), which in this 
context helps people to identify and subsequently adapt their thoughts, behaviours and 
emotions that contribute to fatigue, has been effective in reducing fatigue severity and impact 
in clinical trials (Asano, Berg, Johnson, Turpin, & Finlayson, 2015; Chalder, Deary, Husain, 
& Walwyn, 2010; Nijhof, Bleijenberg, Uiterwaal, Kimpen, & van de Putte, 2012; van Kessel 
et al., 2008). As parental factors may contribute to fatigue, adolescent CFS research has noted 
the importance of involving parents in interventions for fatigue (Chalder et al., 2010). No 
such interventions exist for caMS, thus research in this area is warranted. 
A recent qualitative study suggested that caMS with fatigue have similar cognitive and 
behavioural responses to symptoms to those previously identified in adolescent CFS, such as 
perceiving fatigue as an uncertain, uncontrollable symptom, and engaging in “all-or-nothing” 
patterns of behaviour and daytime napping (Carroll, Chalder, Hemingway, Heyman, & Moss-
Morris, 2016a; Lievesley et al., 2014). To date, much of the literature on psychosocial factors 
related to fatigue in paediatric conditions has been carried out in the context of CFS (Crichton 
et al., 2015). As paediatric fatigue is currently best understood from a biopsychosocial 
perspective in the context of adolescent CFS, assessing similarities and differences in fatigue 
and psychosocial factors between caMS and adolescents with CFS may offer insight into 
fatigue-related factors in paediatric MS. If similar psychosocial factors are associated with 
fatigue in caMS and adolescents with CFS, this may facilitate the development of tailored 
interventions for caMS with fatigue, based on psychological therapies that have been 
effective in treating adolescent CFS.  
Additionally, as previous studies have reported mixed findings on the relationship 
between fatigue and neurocognitive functioning in caMS, it would also be useful to compare 
neurocognitive functioning between groups to assess whether impairments in neurocognitive 
functioning differ in those with and without fatigue. As neurocognitive impairment is likely 
an indicator of greater disease severity in paediatric MS (Julian et al., 2013; MacAllister et 
al., 2005), comparing fatigued and non-fatigued patients on measures of neurocognitive 
functioning may provide insight into whether fatigue is related to disease severity in 
paediatric MS. As an exploratory study, the overall aims were to: : 
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1. Compare fatigue, psychosocial factors previously associated with fatigue, and 
neurocognitive functioning across four groups (a) caMS with fatigue, (b) caMS without 
fatigue, (c) adolescents with CFS, and (d) adolescents without a chronic illness.  
2. Compare parent reports of offspring fatigue across the four groups, and investigate the 
level of agreement between adolescent- and parent-reported fatigue.  
3. Compare parents’ cognitive and behavioural responses to their child’s symptoms and 
parental distress across the four groups. 
Based on previous literature in adult MS and adolescent CFS, our specific hypotheses were: 
1. There would be no differences in fatigue, functional impairment or cognitive and 
behavioural responses to symptoms between caMS with fatigue and adolescents with 
CFS, and both fatigued groups would have greater fatigue, higher functional impairment, 
and more unhelpful cognitive and behavioural responses to symptoms than caMS without 
fatigue and healthy controls. 
2. There would be no differences in parent-reported fatigue, parent-reported cognitive and 
behavioural responses to symptoms, and parental distress between caMS with fatigue and 
adolescents with CFS. Both fatigued groups would have higher parent-reported fatigue, 
more unhelpful cognitive and behavioural responses to symptoms, and higher parental 
distress than caMS without fatigue and healthy controls. 
1. Compare fatigue, psychosocial factors previously associated with fatigue, and 
neurocognitive functioning across four groups (a) caMS with fatigue, (b) caMS without 
fatigue, (c) adolescents with CFS, and (d) adolescents without a chronic illness.  
2. Compare parent reports of offspring fatigue across the four groups, and investigate the 
level of agreement between adolescent- and parent-reported fatigue.  
3. Compare parents’ cognitive and behavioural responses to their child’s symptoms and 
parental distress across the four groups. 
Methods 
Design 
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An observational cross-sectional comparative study design was used.  
Participants 
CaMS aged 6-18 with a confirmed MS diagnosis were included (Polman et al., 2011). 
Children and adolescents with CFS were included if they were aged 6-18 and met the Oxford 
(Sharpe et al., 1991) or CDC (Fukuda et al., 1994) criteria for CFS, but with at least three 
months’ duration rather than six, following National Institute for Health and Care Excellence 
guidelines (NICE, 2007). Healthy controls aged 6-18 with no previous or current physical or 
mental illnesses were included. Primary caregivers of adolescents in all groups were 
included. 
Materials  
Demographic and clinical data: Standard demographic details were collected from all 
participants. Clinical information collected from caMS included age at onset, disease 
duration, treatment type, and treatment duration. 
Child and adolescent measures 
Fatigue “case-ness”: The 11-item version of the Chalder Fatigue Questionnaire (CFQ) using 
bimodal [0, 0, 1, 1] scoring was used to divide caMS into “fatigued” and “non-fatigued” 
groups, using a cut-off of 4. This cut-off was chosen as a score of 4 or above indicates 
clinically significant fatigue. This measure has been shown to be valid and reliable in adult 
populations (Chalder et al., 1993), and has been used widely in the paediatric literature 
(Bould, Collin, Lewis, Rimes, & Crawley, 2013; Chalder, Tong, & Deary, 2002; Crawley, 
Hunt, & Stallard, 2009). 
Fatigue severity was measured using the Paediatric Quality of Life Inventory – Multi-
dimensional Fatigue Scale (PedsQL-MFS). This is a valid and reliable measure of fatigue 
with three subscales: general, cognitive and sleep/rest fatigue, scored on a 5-point Likert 
scale (0, never to 4, always) and transformed to a 100-point scale. Lower scores indicate 
higher fatigue (Varni, Burwinkle, & Szer, 2004). 
Functional impairment was measured using the adolescent version of the five-item Work 
and Social Adjustment Scale (WSAS), which has previously been used in the adolescent 
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fatigue literature. The scale measures impairment in school, social and private leisure 
activities on an eight-point scale (Chalder et al., 2010; Mundt, Marks, Shear, & Greist, 2002). 
Work was replaced with school/college.  
School attendance rate was measured by dividing actual by expected attendance hours. 
Cognitive and behavioural responses to symptoms were measured using the Cognitive and 
Behavioural Responses to Symptoms Questionnaire (CBRQ), which measures fear 
avoidance, symptom catastrophising, damage beliefs, embarrassment avoidance, all-or-
nothing behaviour, and avoidance-rest behaviour. The CBRQ has previously been shown to 
predict ongoing symptom experience, fatigue and impairment in MS and CFS (Knoop et al., 
2012; Skerrett & Moss-Morris, 2006). It has been validated in adults with CFS (Ryan, 
Vitoratou, Goldsmith, & Chalder, 2018) and is used clinically with adolescents with CFS. 
Sleep behaviour was assessed using the Adolescent Sleep Hygiene Scale (ASHS), a reliable 
28-item scale that measures positive and inhibitory sleep behaviours on a six-point scale (1 = 
always, 6 = never). Higher scores indicate better sleep practices (LeBourgeois, Giannotti, 
Cortesi, Wolfson, & Harsh, 2005; Lewandowski, Toliver-Sokol, & Palermo, 2011). 
Psychological difficulties were measured using the Strengths and Difficulties Questionnaire 
(SDQ), which provides a continuous measure of internalising difficulties, encompassing 
emotional and peer problems, and externalising problems, including behavioural and 
hyperactivity problems in children and adolescents (Goodman, 2001). 
Neurocognitive functioning was assessed in children aged 16 or younger using a short-form 
version of the Wechsler Intelligence Scale for Children – Fourth Edition (WISC-IV) 
(Crawford, Anderson, Rankin, & MacDonald, 2010; Wechsler, 2003) and in adolescents aged 
17 or older using the Wechsler Adult Intelligence Scale – Fourth Edition (WAIS-IV) 
(Wechsler, 2014). Both measures provide evaluation of expressive and receptive language, 
non-verbal reasoning, working memory, and timed visual motor integration.  These measures 
have previously been used in paediatric MS research to capture cognitive impairment and 
decline (Amato et al., 2008; MacAllister et al., 2005). 
Parent measures 
Parent-reported fatigue was assessed using the PedsQL-MFS, parent version. 
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Parent cognitive and behavioural responses to symptoms were assessed using the fear-
avoidance, damage beliefs and catastrophising subscales of the CBRQ parent version, which 
assesses parents’ beliefs about their children’s symptoms and their management.   
Parental distress was measured using the General Health Questionnaire (GHQ-12), a 12-
item questionnaire that measures general distress levels in adults (Goldberg, 1992).  
Procedure 
Ethical approval was granted by the West London and GTAC NHS Research Ethics 
Committee [REC Ref: 15/LO/0091], and R&D departments at participating hospitals. CaMS 
and adolescents with CFS were recruited through NHS specialist paediatric neurology or 
chronic fatigue services and online advertisements on MS and CFS charity websites. At NHS 
clinics, eligible participants were identified by a member of the child’s clinical team and 
invited to participate during clinic appointments or by invitation letter. Healthy controls were 
recruited from schools and through online advertisements. All parents, children and 
adolescents provided informed consent or assent, where appropriate. Participants completed a 
battery of self-report questionnaires and had one meeting with a member of the research team 
to complete the WISC-IV/WAIS-IV, age-dependent. Where caMS had completed a WISC-
IV/WAIS-IV as part of routine care in the previous 12 months, scores were taken from 
patient notes as practice effects invalidate a repeat assessment within a one-year period. 
Scores are unlikely to change within this time-frame (Wechsler, 2003). 
Analysis 
Statistical analyses were conducted using IBM SPSS version 22. Overall, less than 5% of 
individual data points were missing, thus missing data were handled using mean imputation. 
However, approximately 30% of neurocognitive data was missing from the MS and CFS 
groups, and 15% from healthy controls. The most common reason for non-completion of the 
WISC-IV/WAIS-IV was participants living too far from London to travel.  Descriptive 
statistics were run to profile groups and, where appropriate, one-way ANOVA or chi-squared 
tests were performed to identify differences in participant characteristics across groups. When 
comparing fatigue and psychosocial factors across groups, caMS were grouped as ‘fatigued’ 
or ‘non-fatigued’ using the CFQ. Differences in group means on measures of fatigue, 
psychosocial factors and neurocognitive functioning were compared using one-way ANOVA, 
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with post-hoc Tukey tests where the assumption of homogeneity of variances was met, and 
Welch’s ANOVA with Games-Howell post-hoc tests where Levene’s test indicated the 
assumption of homogeneity of variances was violated. Pearson correlations assessed 
agreement between self- and parent-reported fatigue. To account for multiple comparisons, a 
significance value of p < 0.01 was applied. 
Results 
Reliability analysis 
All measures demonstrated high reliability in the total sample with α approaching or 
exceeding .90, except for the Adolescent Sleep Hygiene Scale, which demonstrated good 
reliability (α = .71). 
Demographics 
A total of 175 participants were recruited; 30 caMS and 30 of their parents, 30 adolescents 
with CFS and 28 of their parents, and 30 healthy controls and 27 of their parents. 
Demographic characteristics of all groups are presented in Tables 1 and 2. 
Table 1. Child and adolescent demographics characteristics across groups 
 MS (n = 30) CFS (n = 30) HC (n = 30) One-way ANOVA or 2 tests 
for group comparisons 
Age (years), M 
(range) 
15.87  
(9.27-18.95) 
15.67 
(12.24.18.00) 
15.02  
(8.54-18.54) 
F (2, 87) = .87, p = .45 
Gender (n female) 18 21 18 2 (2) = .86, p = .65 
Nationality (n) 
   British 
   Non-British  
 
21 
9 
 
30 
0 
 
24 
6 
2 (2) = 11.46, p = .003 
 
Ethnicity (n) 
   White  
   Black  
   Mixed  
   Asian 
   Other 
 
 
16 
5 
3 
4 
2 
 
 
26 
0 
3 
1 
0 
 
 
23 
1 
2 
4 
0 
2 (2) = 8.75, p = .013 
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Table 2. Parent demographics characteristics across groups 
 MS (n = 30) CFS (n = 28) HC (n = 27) One-way ANOVA or 2 tests 
for group comparisons 
Age (years), mean 
(range) 
46.75  
(32.70, 65.47) 
48.16  
(38.56, 57.81) 
45.06  
(34.15, 50.67) 
F (2, 82) = 1.60, p = .21 
Relationship to child (n) 
 Mother  
 Father  
 
 
25 
5 
 
 
27 
1 
 
 
25 
2 
2 (4) = .43, p = .43 
Nationality (n) 
 British  
 Non-British  
 
 
20 
10 
 
 
28 
00 
 
 
22 
5 
2 (2) = 11.09, p = .004 
Ethnicity (n) 
 White  
   Black 
   Mixed 
   Asian 
 Other 
 
 
18 
6 
3 
1 
2 
 
 
26 
1 
0 
1 
0 
 
 
23 
2 
0 
2 
0 
2 (2) = 16.51, p = .09 
Group Comparisons 
When dividing caMS into ‘fatigued’ and ‘non-fatigued’ groups on the CFQ, 50% scored ≥4, 
resulting in a sample size of 15 in each group. When comparing fatigued and non-fatigued 
caMS on MS-related factors, there were no significant differences in age at onset, illness 
duration, number of relapses, or treatment duration (Table 3). Means, standard deviations and 
results of one-way or Welch’s ANOVA for group comparisons in adolescent outcomes are 
shown in Table 4, and parent outcomes in Table 5. Post-hoc test results for all between group 
comparisons are reported in supplementary materials 1, and key findings are reported in the 
main text. 
Table 3. Clinical characteristics of MS fatigued and non-fatigued groups 
 
Variable MS Fatigued 
(n = 15) 
MS Non-fatigued 
(n = 15) 
Independent samples 
t-test to compare 
means 
Age at MS onset (mean ± SD) 12.97 ± 4.32 12.62 ± 3.47 t (28) = .25, p = .81 
Illness Duration months (mean ± SD) 3.29 ± 3.76 2.87 ± 2.27 t (28) = .37, p = .71 
Relapse in past year (mean ± SD) 1.33 ± 1.63 1.27 ± 1.44 t (28) = .12, p = .91 
Treatment type 
Injectable treatment (n) 
Oral treatment (n) 
Monthly Infusion (n) 
Vitamin D (n) 
None (n) 
 
5 
5 
1 
3 
1 
 
10 
3 
2 
 
Treatment duration months (mean ± SD) 9.38 ± 7.54 13.63 ± 11.86 t (19) = -1.01, p = .33 
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Fatigue severity and functional impairment 
One-way ANOVA demonstrated a significant main effect of group across all self- and 
parent- measures of fatigue severity (Tables 4 and 5). Post-hoc tests showed that self- and 
parent-reported general, sleep and cognitive fatigue were significantly higher in both fatigued 
groups than in both non-fatigued groups (all p <.001), except for parent-reported fatigue in 
caMS. Parent-reported general and sleep fatigue were significantly higher in fatigued caMS 
than in non-fatigued caMS (both p = .002), but parent-reported cognitive fatigue did not 
differ between these groups (figure 1). There were no significant differences between 
fatigued caMS and adolescents with CFS on any measure of self- or parent-reported fatigue 
severity (supplementary materials 1). All parent and self-reported fatigue variables were 
significantly correlated: general fatigue (r = .78, p < .001), sleep fatigue (r = .80, p < .001) 
and cognitive fatigue (r = .71, p = .001).  
There was a significant main effect of group on functional impairment. Fatigued 
caMS reported significantly greater functional impairment than healthy controls (p = .001). 
Adolescents with CFS reported significantly greater functional impairment than healthy 
controls (p < .001) and non-fatigued caMS (p < .001). There were no significant differences 
between non-fatigued caMS and fatigued caMS or healthy controls (Supplementary materials 
1).  
 
Figure 1. Bar charts showing group differences in mean self- and parent-reported fatigue 
scores on the general, sleep and cognitive fatigue subscales of the PedsQL-MFS. Note: lower 
scores indicate higher fatigue. CFS = chronic fatigue syndrome, HC = healthy controls. 
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Table 4. Between group comparisons across self-report measures of fatigue and psychosocial factors 
 Group means and standard deviations M (SD) One-way or Welch ANOVA for group comparisons 
 MS-fatigue (n = 15) MS non-fatigue (n=15) CFS (n = 30) HC (n = 30)  
Self-reported fatigue severity 
Self-reported general fatigue 
Self-reported sleep fatigue 
Self-reported cognitive fatigue  
 
33.89 (18.15) 
45.56 (20.80) 
41.39 (28.28) 
 
73.61 (13.24) 
70.83 (13.55) 
76.39 (23.61) 
 
26.81 (19.07) 
35.28 (16.15) 
37.08 (18.16) 
 
74.17 (17.38) 
66.67 (18.83) 
74.03 (21.54) 
 
F (3) = 49.66, p < .001 
F (3) = 22.33, p < .001 
F (3) = 20.39, p < .001 
Functional impairment a 16.80 (11.66) 6.47 (5.74) 23.80 (10.09) 1.67 (3.79) F (3) = 46.06, p < .001 
School attendance rate a .76 (.24) .95 (.12) .62 (.34) .97 (.12) F (3) = 10.53, p < .001 
Sleep Behaviour 
Physiological  
Behavioural arousal 
Cognitive/emotional a 
Sleep environment a 
Sleep stability 
Daytime sleepiness a 
 
4.67 (.82) 
4.04 (1.05) 
3.90 (.96) 
4.96 (1.09) 
3.02 (1.05) 
4.33 (1.30) 
 
4.83 (.65) 
3.42 (1.19) 
4.61 (.98) 
5.28 (.55) 
3.38 (1.50) 
5.40 (.66) 
 
4.90 (.64) 
3.54 (.92) 
4.09 (.97) 
5.55 (.54) 
3.59 (1.32) 
4.80 (1.44) 
 
4.77 (.63) 
3.82 (1.22) 
4.58 (.63) 
5.47 (.61) 
3.26 (1.03) 
5.60 (.78) 
 
F (3) = .418, p = .741 
F (3) = 1.14, p = .337 
F (3) = 3.30, p = .031 
F (3) = .174, p = .175 
F (3) = .81, p = .493 
F (3) = 5.44, p = .003 
CBRQ 
Fear avoidance 
Catastrophising 
Damage beliefs 
Embarrassment avoidance a 
 
12.80 (5.25) 
7.13 (4.47) 
11.13 (3.62) 
11.63 (7.96) 
 
9.60 (5.01) 
4.80 (4.66) 
9.13 (3.40) 
6.00 (4.39) 
 
14.33 (3.58) 
8.23 (3.46) 
11.80 (3.03) 
11.77 (5.73) 
 
9.80 (5.30) 
3.00 (3.01) 
7.82 (3.97) 
5.41 (5.00) 
 
F (3) = 5.96, p = .001 
F (3) = 10.91, p < .001 
F (3) = 7.23, p < .001 
F (3) = 8.76, p < .001 
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Table 4. Between group comparisons across self-report measures of fatigue and psychosocial factors 
 Group means and standard deviations M (SD) One-way or Welch ANOVA for group comparisons 
 MS-fatigue (n = 15) MS non-fatigue (n=15) CFS (n = 30) HC (n = 30)  
Symptom focusing 
All-or-nothing behaviour 
Avoidance-rest behaviour a 
12.07 (4.96) 
10.07 (6.41) 
11.33 (5.39) 
8.67 (4.70) 
5.53 (3.83) 
8.00 (5.86) 
14.23 (4.80) 
9.60 (5.56) 
12.90 (4.88) 
7.28 (6.24) 
4.03 (4.34) 
7.38 (7.50) 
F (3) = 9.55, p < .001 
F (3) = 8.22, p < .001 
F (3) = 4.95, p = .005 
Psychological difficulties 
Internalising problems a 
Externalising problems a 
 
7.60 (4.74) 
6.00 (5.31) 
 
3.80 (2.83) 
3.93 (2.99) 
 
6.48 (2.78) 
6.22 (2.84) 
 
3.56 (3.45) 
4.32 (2.84) 
 
F (3) = 5.27, p = .005 
F (3) = 2.52, p = .079 
Cognitive Functioning 
Verbal Comprehension 
Perceptual Reasoning  
Working Memory 
Processing Speed a 
Full Scale IQ 
(n = 8) 
101.57 (11.52) 
98.43 (11.67) 
91.14 (18.01) 
84.14 (17.56) 
92.14 (14.69) 
(n = 11) 
91.82 (15.30) 
89.36 (12.82) 
95.91 (9.48) 
83.64 (21.97) 
86.91 (16.20) 
(n = 22) 
103.95 (10.25) 
101.86 (7.69) 
99.41 (10.42) 
99.91 (9.13) 
102.45 (9.86) 
(n = 25) 
109.12 (12.70) 
102.44 (10.21) 
104.84 (14.24) 
106.88 (10.78) 
107.72 (10.74) 
 
F (3) = 5.12, p = .003 
F (3) = 4.84, p = .004 
F (3) = 2.67, p = .053 
F (3) = 6.81, p = .003 
F (3) = 9.09, p < .001 
Note: On the PedsQL-MFS, higher scores indicate lower fatigue and vice versa. a equal variances not assumed – results of Welch ANOVA presented; Abbreviations: MS = multiple sclerosis, CFS = 
chronic fatigue syndrome, HC = healthy control, CBRQ = cognitive and behavioural responses to symptoms.  
Questionnaire scoring: PedsQL-MFS (fatigue severity): Scored on a 5 point Likert scale and transformed to a 100-point scale where higher scores indicate lower fatigue (i.e. 100 = not at all fatigued); 
WSAS (functional impairment): scored from 0 to 40, higher scores indicate greater functional impairment; CBRQ (cognitive and behavioural responses to symptoms): Each subscale is scored out of a 
different total score, where higher scores indicate more unhelpful responses: fear avoidance (0-24), catastrophising (0-16), damage beliefs (0-20), embarrassment avoidance (0-24), symptom focusing (0-
24), all-or-nothing behaviour (0-20), avoidance-rest behaviour (0-32); ASHS (Sleep): Each item is scored on a six-point Likert scale, where higher scores indicate better sleep practices. 
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Table 5. Between group comparisons across parent-report measures of fatigue and parent psychosocial factors 
 Group means and standard deviations M (SD) One-way or Welch ANOVA for group comparisons 
 MS-fatigue (n = 15) MS non-fatigue (n=15) CFS (n = 28) HC (n = 27)  
 Parent-reported fatigue severity 
Parent-reported general fatigue 
Parent-reported sleep fatigue 
Parent-reported cognitive fatigue  
 
40.00 (21.41) 
42.50 (21.66) 
49.72 (31.83) 
 
64.72 (21.24) 
65.83 (17.97) 
61.94 (22.26) 
 
25.00 (13.18) 
30.80 (12.34) 
33.78 (16.41) 
 
79.94 (19.03) 
78.55 (18.62) 
81.48 (15.94) 
 
F (3) = 46.37, p < .001 
F (3) = 39.49, p < .001 
F (3) = 25.02, p < .001 
Parent CBRQ 
Parent fear avoidance beliefs  
Parent catastrophising 
Parent damage beliefs 
 
13.40 (6.61) 
8.60 (3.00) 
10.73 (3.81) 
 
9.95 (2.69) 
6.20 (2.65) 
11.27 (3.03) 
 
15.89 (3.76) 
9.18 (3.67) 
13.64 (3.18) 
 
7.07 (4.36) 
2.67 (3.46) 
6.67 (3.21) 
 
F (3) = 19.68, p < .001 
F (3) = 19.95, p < .001 
F (3) = 21.14, p < .001 
Parental Distress 15.53 (5.79) 11.87 (5.01) 15.68 (5.43) 10.67 (5.56) F (3) = 5.02, p = .003 
Note: On the PedsQL-MFS, higher scores indicate lower fatigue and vice versa. a equal variances not assumed – results of Welch ANOVA presented; Abbreviations: MS = multiple sclerosis, CFS = 
chronic fatigue syndrome, HC = healthy control, CBRQ = cognitive and behavioural responses to symptoms 
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School Attendance Rate 
School attendance was high in healthy controls (M = 97%) and non-fatigued caMS (M 
= 95%), but lower in fatigued caMS (M = 76%) and adolescents with CFS (M = 62%). 
Welch’s ANOVA demonstrated a significant main effect of group on school attendance 
(Table 4). Post-hoc Games-Howell tests showed significantly lower school attendance in 
adolescents with CFS than in non-fatigued caMS and healthy controls (both p < .001, 
supplementary materials 1), but showed no other differences between groups. 
Neurocognitive Functioning 
Descriptive statistics indicated that over 90% of healthy controls and over 86% of 
adolescents with CFS scored within or above average population norms (90-109) on all 
measures of neurocognitive functioning, with the remainder scoring within the low average 
range (80-89) (Table 4). CaMS, however, appeared to have impaired performance on all 
measures, with only 66.7% scoring within or above population norms on verbal 
comprehension, 55.6% on perceptual reasoning, 61% on working memory, 38.9% on 
processing speed, and 55.6% on full scale IQ. Processing speed appeared most affected, with 
27.8% scoring low average, and 23.3% scoring within the borderline (70-79) or extremely 
low range (≤ 69). Almost 28% of caMS scored within these ranges on full scale IQ, 16.7% on 
verbal comprehension and working memory, and 11.2% on perceptual reasoning. 
One-way ANOVA demonstrated a significant main effect of group on verbal 
comprehension, perceptual reasoning, processing speed and full-scale IQ (Table 4). Post-hoc 
Tukey tests showed that non-fatigued caMS had significantly lower verbal comprehension 
scores than healthy controls (p = .001), but there were no other between-group differences on 
this subtest. Non-fatigued caMS had significantly lower perceptual reasoning scores than 
adolescents with CFS (p = .007) and healthy controls (p = .004), and significantly lower full-
scale IQ than adolescents with CFS (p = .004) and healthy controls (p < .001). There were no 
differences between fatigued and non-fatigued caMS on any measure of neurocognitive 
functioning. Post-hoc Games-Howell tests showed no significant between group differences 
on processing speed (supplementary materials 1).   
Adolescent cognitive and behavioural responses to symptoms 
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One-way ANOVA demonstrated a significant main effect of group on all subscales of 
the CBRQ (Table 4). Post-hoc tests showed that fatigued caMS reported significantly greater 
catastrophising (p = .004), and all-or-nothing behaviour (p = .002) than healthy controls, but 
did not significantly differ to adolescents with CFS or non-fatigued caMS on any CBRQ 
subscale (Figure 2). Adolescents with CFS reported significantly higher catastrophising, 
damage beliefs, embarrassment avoidance, symptom focusing, all-or-nothing behaviour, 
avoidance-rest behaviour (all p < .001) and fear avoidance (p = .002) than healthy controls, 
and reported significantly greater symptom focusing (p = .008) and embarrassment avoidance 
(p = .003) than non-fatigued caMS (supplementary materials 1).  
 
Figure 2. Group differences in mean subscale scores on the adolescent Cognitive and 
Behavioural Responses to Symptoms Questionnaire. CFS = Chronic Fatigue Syndrome, HC 
= healthy controls. 
Parent cognitive and behavioural responses to symptoms 
One-way ANOVA demonstrated a significant main effect of group across all measures 
of parents’ cognitive and behavioural responses to their children’s symptoms (Table 5). Post-
hoc Tukey tests showed that parents of fatigued caMS and adolescents with CFS reported 
significantly higher fear avoidance beliefs, damage beliefs and catastrophising than parents of 
healthy controls, and parents of adolescents with CFS reported significantly higher fear 
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avoidance beliefs than parents of non-fatigued caMS (all p<.001). Parents of non-fatigued 
caMS reported significantly higher damage beliefs (p<.001) and catastrophising than parents 
of healthy controls (all p=.008). 
Sleep 
Mean physiological arousal, cognitive/emotional, sleep environment and daytime 
sleepiness scores indicated that adolescents in all groups generally engage in positive sleep 
behaviours. However, on the behavioural arousal and sleep stability subscales, mean scores 
suggested that adolescents in all groups may engage in behaviours that inhibit sleep. One-way 
or Welch’s ANOVA demonstrated no significant main effect of group on any sleep variable, 
except for daytime sleepiness (Table 4). Games-Howell post-hoc tests indicated no 
significant differences between groups at the p < 0.01 level. At the p < 0.05 level, fatigued 
caMS had significantly higher daytime sleepiness scores than non-fatigued caMS and healthy 
controls, and adolescents with CFS had significantly higher scores than healthy controls. 
Internalising and externalising difficulties 
Welch’s ANOVA demonstrated a significant main effect of group on the internalising 
difficulties, but not on the externalising difficulties subscale of the SDQ (Table 4). Post-hoc 
Games-Howell tests found no significant between group differences in internalising 
difficulties (supplementary materials 1). 
Parental Distress 
Mean psychological distress scores were elevated in parents of fatigued caMS and 
parents of adolescents with CFS, while parents of non-fatigued caMS and healthy controls all 
scored within the normal range on the GHQ-12. One-way ANOVA demonstrated a 
significant main effect of group on parental distress (Table 5). Post-hoc Tukey tests showed 
greater parental distress in the CFS group when compared to healthy controls (p = .006), but 
found no other significant differences between groups. 
Discussion 
This study provides a novel insight into fatigue, psychosocial factors and cognitive 
functioning in children and adolescents with MS, CFS and without a chronic illness. Fifty 
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percent of caMS in our sample reported clinically significant fatigue. Fatigued caMS reported 
similar levels of fatigue severity to adolescents with CFS on both self- and parent-report 
measures, with high agreement between self- and parent reports. Both fatigued groups 
reported similar levels of functional impairment, which were higher than in the non-fatigued 
groups, highlighting the disabling nature of fatigue. Adolescents with CFS had the lowest 
school attendance. School attendance did not significantly differ between adolescents with 
CFS and fatigued caMS, suggesting that reduced school attendance is also problematic for 
fatigued caMS. Consistent with previous paediatric and adult MS literature, this study found 
no clinical or demographic differences between fatigued and non-fatigued caMS, but 
indicated some possible parallels between psychosocial factors in fatigued caMS and 
adolescents with CFS. 
This was the first study to quantitatively explore cognitive and behavioural responses to 
symptoms in caMS and their parents. There were no differences between fatigued caMS and 
adolescents with CFS in cognitive and behavioural responses to symptoms, and fatigued 
caMS reported higher all-or-nothing behaviour and symptom catastrophising than healthy 
controls. This echoed recent qualitative data where fatigued caMS described engaging in all-
or-nothing patterns of behaviour in response to fatigue, and feeling that fatigue was uncertain 
and uncontrollable (Carroll et al., 2016a). Both these factors have previously shown 
associations with fatigue in adult MS and adolescent CFS, and strategies directed at 
modifying these behaviours and cognitions have been incorporated into CBT based 
interventions for fatigue (Chalder et al., 2010; Moss-Morris et al., 2012). As previous 
literature on adolescent CFS has informed the development of effective interventions for 
adolescent fatigue, the similarities identified between fatigued caMS and adolescents with 
CFS offer new insights into paediatric MS fatigue, and highlights potential targets for tailored 
interventions for caMS with fatigue. 
Notably, there were no significant differences between fatigued and non-fatigued caMS 
on adolescent cognitive and behavioural responses to symptoms, although descriptive data 
suggested that responses of fatigued caMS were closer to those of adolescents with CFS, 
while responses of non-fatigued caMS appeared closer to those of healthy controls. The 
sample sizes may have been too small to detect differences between the MS groups. 
However, it is worth considering that non-fatigued caMS may also engage in unhelpful 
cognitive and behavioural responses to symptoms not specific to fatigue, as they likely 
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experience other MS symptoms similar to fatigued caMS. Therefore, it may be useful to 
explore these factors in the wider context of adjustment and symptom management in 
paediatric MS, rather than solely in a fatigue-specific context.   
This was reflected in parents’ cognitive behavioural responses to symptoms, as parents 
of all illness groups reported significantly higher damage beliefs and catastrophising than 
parents of healthy controls, indicating that parents’ cognitive behavioural responses to 
symptoms are similar regardless of fatigue. It should be acknowledged that caMS and 
adolescents with CFS experience more severe and serious symptoms than healthy controls, 
thus it is natural for parents to have greater concerns. However, fear avoidance beliefs 
appeared to be specific to parents in the fatigue groups, suggesting that parents of fatigued 
caMS and adolescents with CFS have greater concerns about exercise and activity when their 
children experience symptoms. As exercise and activity have been shown to benefit adults 
with MS fatigue and adolescents with CFS, addressing parents’ fear avoidance beliefs may be 
an important target for intervention. 
It was notable that fatigued and non-fatigued caMS did not significantly differ on any 
domain of neurocognitive functioning or full scale IQ.  Non-fatigued caMS, but not fatigued 
caMS, had lower perceptual reasoning, verbal comprehension and full scale IQ scores 
compared to adolescents with CFS and healthy controls. Though the MS sample sizes may 
have been too small to detect differences between groups, these findings suggest that 
impaired cognitive functioning is problematic for caMS regardless of fatigue. Mean scores 
across all domains of neurocognitive functioning indicated that a substantial proportion of 
caMS scored in the low average, borderline or extremely low range compared to population 
norms. As impairment in neurocognitive functioning has the potential to significantly impede 
caMS’ school performance and future academic attainment, supporting caMS with 
neurocognitive impairment should be prioritised in schools and clinical practice. In line with 
previous studies’ recommendations, incorporating regular neuropsychological assessments as 
part of routine care is key to supporting caMS in a clinical context (Amato et al., 2014). 
Parental distress differed between groups, although the same was not true for 
adolescents. Parental distress was significantly higher in parents of adolescents with CFS 
than in parents of healthy controls and mean scores indicated elevated distress in parents of 
fatigued caMS, supporting previous studies in adolescent CFS which highlighted the 
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importance of measuring parental distress in the context of fatigue. As this study was cross-
sectional, causality cannot be inferred from our findings. However, functional impairment in 
school and recreational activities in fatigued caMS could be quite distressing for parents. 
Alternatively, parental distress could contribute to children’s fatigue.  
Finally, this study offered interesting insights into adolescent sleep behaviour. 
Although there were no significant differences between groups on any sleep variable, mean 
scores of all groups indicated that adolescents may regularly engage in unhelpful sleep 
behaviours, particularly regarding sleep stability and behavioural arousal. Trends in the data 
suggested that fatigued caMS had higher daytime sleepiness than non-fatigued caMS and 
healthy controls, but did not differ from adolescents with CFS, indicating that adolescents 
with fatigue nap more during the day. As daytime napping, irregular sleep patterns and 
activities such as using phones or watching television before bed can all contribute to fatigue 
and negatively impact health, it would be useful to explore these factors in future research 
(Owens, 2014). These factors may be important potential targets both for interventions in the 
wider context of adolescent sleep behaviour, and interventions for fatigued caMS.   
Limitations 
The study is limited by its small sample, particularly where separating caMS into 
fatigued and non-fatigued subgroups resulted in smaller groups. It’s possible that the study 
was underpowered to detect between-group differences in some variables. There were 
missing neurocognitive data, which limits the conclusions that can be drawn from between-
group comparisons of neurocognitive functioning. Though the p-value was adjusted to reduce 
the type 1 error risk, this study was also limited by the number of comparisons conducted. 
Participants in our sample were recruited from specialist services.  Attempts were made to 
contact all relevant patients in these services but not all patients provided informed consent.   
Others were recruited through online platforms where participants opted in to the study. As 
for ethical reasons we were unable to collect data on the differences between those who 
participated and those who did not, our sample may not be representative.    
Conclusions and Future Directions 
Fatigue is clearly a significant issue for 50% of caMS in our sample, and intervention 
for this symptom is much needed. Similarities in adolescents’ and parents’ cognitive and 
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behavioural responses to symptoms between fatigued caMS and adolescents with CFS 
suggest that it may be useful to tailor existing CFS cognitive behavioural interventions for 
caMS and their parents. Interventions should target these similar factors, and factors 
previously associated with paediatric MS fatigue, such as managing school and issues around 
disclosure of MS and fatigue. It would be beneficial to routinely screen for fatigue in caMS in 
clinical practice so that timely intervention may be offered when it is problematic. This study 
also highlighted impaired cognitive abilities in caMS regardless of fatigue, highlighting the 
need to routinely assess neurocognitive functioning in clinical practice so appropriate support 
may be provided. As paediatric MS is rare, which makes it difficult to address the problem of 
small sample sizes, future research would benefit from adopting a collaborative multi-centre 
international approach to obtain sample sizes large enough to conduct more in-depth studies. 
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